Moonwalk Biosciences

Moonwalk Biosciences is a genomic medicine company pioneering precision epigenetic drugs. By targeting the epigenetic code—the software of the genome—Moonwalk aims to reprogram cells to a healthy state, offering a fundamentally new approach to discovering and developing therapies. Moonwalk is the first company to combine an epigenetic discovery platform with precision engineering, opening new targeted spaces for complex diseases. Moonwalk's focus on epigenetic engineering leverages comprehensive read-write technologies to develop potential treatments for a wide range of diseases at their root cause.